Persistent Functional Immune Defects in Treated HIV Infection
HIV感染治疗后持续存在功能性免疫缺陷
基本信息
- 批准号:10593968
- 负责人:
- 金额:$ 18.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-07 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS clinical trial groupAcquired Immunodeficiency SyndromeAddressAdipose tissueAgingAnti-Inflammatory AgentsAutomobile DrivingAwardBlood VesselsCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCaliforniaCardiovascular systemCellsCessation of lifeClinicalCytomegalovirusDataDedicationsDefectDiabetes MellitusDiseaseEducational workshopEnvironmentEpithelial CellsEtiologyEventExhibitsFoundationsFrequenciesFundingGrantHIVHIV InfectionsHIV SeropositivityHeart DiseasesImmuneImmunologic Deficiency SyndromesImmunologicsImpairmentIndividualInflammationInflammatoryInsulin ResistanceInternationalInterventionK-Series Research Career ProgramsLaboratoriesLife ExpectancyLinkMalignant neoplasm of lungMediatingMedicineMentored Research Scientist Development AwardMentorsMentorshipMid-Career Clinical Scientist Award (K24)ModernizationMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusOrganPathway interactionsPeer ReviewPeptidesPersonsPhasePhysiciansPlacebosPopulationProcessProductivityPublicationsRandomized, Controlled TrialsRecoveryReportingResearchResearch InstituteResearch PersonnelResearch TrainingRiskRoleSan FranciscoScienceScientistSecureSeriesSmokingSubstance Use DisorderT cell infiltrationT-Cell ActivationT-LymphocyteTNF geneTimeTrainingTraining ActivityTraining ProgramsUniversitiesValganciclovirVascular DiseasesVascular EndotheliumViralantiretroviral therapybasecardiometabolismcareercareer developmentco-infectioncohortcollaboratorydisorder riskgastrointestinal epitheliumhigh riskimmune activationimprovedindexinginflammatory markerinhibitorinterestlifestyle factorsmicrobialmid-career facultymortalitymultidisciplinarypatient oriented researchprogramsskillsskills trainingsystemic inflammatory response
项目摘要
Project Summary
Peter Hunt, MD is an Associate Professor of Medicine in the UCSF Division of Experimental Medicine and an
internationally recognized leader in translational Patient-Oriented Research (POR) focused on the causes and
consequences of immune activation in treated HIV infection. He is submitting this K24 Mid-Career
Development application to afford him protected time to mentor junior investigators, to provide him with
dedicated mentorship skills training, and to continue to grow his POR program. The candidate: This proposal
will build upon Dr. Hunt's highly productive research program, exemplified by over 200 peer-reviewed
publications, a citation h-index of 52, and robust research funding base including three R01 grants and two
large projects in the DARE collaboratory and amfAR Institute for HIV Cure Research. He has already
demonstrated a strong track record for mentoring, particularly in multidisciplinary team science, including 4
mentees who have successfully applied for K23/K01 awards, and two who have gone on to secure
independent R-series grants. He is also the recipient of the 2015 UCSF AIDS Research Institute Award for
Mentoring. The environment: He has a rich foundation for supporting his mentees including access to the
UCSF SCOPE cohort of >2000 HIV-infected individuals in San Francisco and connections to several other
multicenter cohorts (LSOCA, UARTO, CNICS) and research networks including the ACTG, where he served
as Chair of the Inflammation and End Organ Disease Committee. Mentorship training: This K24 award will
further enhance his mentorship skills through intensive workshops and training modules supported by the
UCSF CTSI Mentorship Training Program and the UCSF-GIVI Mentoring the Mentors program. He will also be
coached by a robust group of career mentors as he navigates this next phase of his career. Research plan:
The overarching hypothesis motivating the research plan is that subclinical immunodeficiency despite treated
HIV infection decreases CD8+ T cell-mediated CMV surveillance, which in turn leads to microbial translocation
and cardiometabolic complications. The specific aims will: 1) assess the contribution of asymptomatic CMV
replication to soluble markers of microbial translocation and vascular dysfunction in treated HIV infection, 2)
assess the degree to which treated HIV infection is associated with inflammatory CMV-specific CD8+ T cell
infiltration of adipose tissue and insulin resistance, and 3) assess whether maturational defects in CMV-specific
CD8+ T cells occur in treated HIV infection. These studies will also serve as ideal POR training platforms for
his mentees.
项目摘要
Peter Hunt,医学博士,加州大学旧金山分校实验医学部医学副教授,
国际公认的以患者为中心的转化型研究(POR)的领导者,专注于原因和
免疫激活在接受治疗的艾滋病毒感染中的后果。他正在提交这份职业生涯中期的K24
开发应用程序,为他提供受保护的时间来指导初级调查人员,为他提供
专注于导师技能培训,并继续发展他的POR计划。候选人:这份提案
将建立在亨特博士富有成效的研究计划的基础上,200多名同行评议是例证
出版物,引文h指数为52,以及强大的研究资金基础,包括三项R01赠款和两项
DARE协作室和AMFAR艾滋病毒治疗研究所的大型项目。他已经这么做了
表现出良好的指导记录,特别是在多学科团队科学方面,包括4
成功申请K23/K01奖项的学员,以及两名继续获得
独立R系列奖助金。他也是2015年加州大学旧金山分校艾滋病研究所奖的获得者
辅导。环境:他有丰富的基础来支持他的学员,包括访问
旧金山加州大学旧金山分校2000名HIV感染者的范围队列及其与其他几个人的联系
多中心队列(LSOCA、UARTO、CNICs)和研究网络,包括他服务的ACTG
担任炎症和最终器官疾病委员会主席。导师培训:这个K24奖项将
通过密集的工作坊和培训模块进一步提高他的指导技能
加州大学旧金山分校的CTSI导师培训计划和UCSF-GIVI导师计划。他也将成为
在他职业生涯的下一阶段,他得到了一群强大的职业导师的指导。研究计划:
激励这项研究计划的首要假设是,尽管治疗了亚临床免疫缺陷,但
HIV感染减少了CD8+T细胞介导的CMV监测,这反过来又导致微生物易位
和心脏新陈代谢并发症。具体目标是:1)评估无症状巨细胞病毒的作用
复制到接受治疗的HIV感染中微生物易位和血管功能障碍的可溶性标志物,2)
评估接受治疗的HIV感染与炎性CMV特异性CD8+T细胞的相关性程度
脂肪组织的渗透和胰岛素抵抗,以及3)评估CMV特异性成熟缺陷
经治疗的HIV感染者体内存在CD8+T细胞。这些研究还将作为理想的POR培训平台
他的师徒。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER W HUNT其他文献
PETER W HUNT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER W HUNT', 18)}}的其他基金
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
治疗无症状 CMV 复制对 HIV 感染治疗者心血管风险的影响
- 批准号:
10715847 - 财政年份:2023
- 资助金额:
$ 18.43万 - 项目类别:
Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIV
评估艾滋病毒感染者代谢健康中脂肪组织产热与纤维化之间的相互关系
- 批准号:
10626188 - 财政年份:2022
- 资助金额:
$ 18.43万 - 项目类别:
Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV
巨细胞病毒 (CMV)、HIV 的肠道屏障和免疫功能障碍
- 批准号:
10177602 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Plasma Proteomic and Metabolomic Predictors of Vascular Disease in Treated HIV
HIV治疗者血管疾病的血浆蛋白质组学和代谢组学预测因子
- 批准号:
10331583 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV
巨细胞病毒 (CMV)、HIV 的肠道屏障和免疫功能障碍
- 批准号:
10875189 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV
巨细胞病毒 (CMV)、HIV 的肠道屏障和免疫功能障碍
- 批准号:
10372191 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Cytomegalovirus (CMV), the gut barrier and immune dysfunction in HIV
巨细胞病毒 (CMV)、HIV 的肠道屏障和免疫功能障碍
- 批准号:
10578682 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
治疗无症状 CMV 复制对 HIV 感染治疗者心血管风险的影响
- 批准号:
10242227 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Persistent Functional Immune Defects in Treated HIV Infection
HIV感染治疗后持续存在功能性免疫缺陷
- 批准号:
9927206 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
治疗无症状 CMV 复制对 HIV 感染治疗者心血管风险的影响
- 批准号:
10449260 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 18.43万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 18.43万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 18.43万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 18.43万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 18.43万 - 项目类别: